Evidence map›Paper›PMID 32373215›Full record

ArticleTheranostics2020

PEX5, a novel target of microRNA-31-5p, increases radioresistance in hepatocellular carcinoma by activating Wnt/β-catenin signaling and homologous recombination.

Jie Wen, Kai Xiong, Abudureyimujiang Aili, Hao Wang, Yuequan Zhu, Zhengquan Yu, Xueyan Yao, Ping Jiang, Lixiang Xue, Junjie Wang

Open access · goldAbstract read
In one paragraph

Article in Theranostics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
2.5field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 57 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Circulating MicroRNA Panel as a Diagnostic Marker for Hepatocellular Carcinoma.The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology · 2022
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Jie WenPeking University Third Hospital, Beijing 100191, China.
Kai XiongPeking University Third Hospital, Beijing 100191, China.
Abudureyimujiang AiliPeking University Third Hospital, Beijing 100191, China.
Hao WangPeking University Third Hospital, Beijing 100191, China.
Yuequan ZhuBeijing Luhe Hospital, Capital Medical University, Beijing 101149, China.
Zhengquan YuCollege of Biological Sciences, China Agricultural University, Beijing 100193, China.
Xueyan YaoPeking University People's Hospital, Beijing 100044, China.
Ping JiangPeking University Third Hospital, Beijing 100191, China.
Lixiang XuePeking University Third Hospital, Beijing 100191, China.
Junjie WangPeking University Third Hospital, Beijing 100191, China.
Peking University · CNPeking University Third Hospital · CNBeijing Luhe Hospital Affiliated to Capital Medical University · CNChina Agricultural University · CNPeking University People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

beta CateninCarcinoma, HepatocellularCell CycleGene Expression Regulation, NeoplasticHumansLiver NeoplasmsMicroRNAsPeroxisome-Targeting Signal 1 Receptorbeta CateninMicroRNAsMIRN31 microRNA, humanPeroxisome-Targeting Signal 1 ReceptorPEX5 protein, humanHomologous RecombinationmiR-31-5pPEX5Radiosensitivityβ-catenin

Identifiers

PMID32373215
PMCPMC7196300
OpenAlexW3015436153

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.